Self-inactivating gammaretroviral vector
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Self-inactivating gammaretroviral vector, covering 2026-04-21 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: Gene Transfer for Severe Combined Immunodeficiency, X-linked (SCID-X1) Using a Self-inactivating (SIN) Gammaretroviral Vector [Phase 1, Phase 2]